x
sAM lipworth • Department of Tropical Medicine and Global Health, University of
Oxford, Oxford, UK
José luis MArtíNez • Departamento de Biotecnología Microbiana, Centro Nacional de
Biotecnología, CSIC, Madrid, Spain
iVAN MAtic • INSERM U1001, Université Paris-Descartes, Sorbonne Paris Cité, Faculté
de Médecine Paris Descartes, Paris, France; Centre National de la Recherche Scientifique
(CNRS), Paris, France
gAreth McVicker • Krebs Institute, University of Sheffield, Sheffield, UK; Department
of Molecular Biology and Biotechnology, University of Sheffield, Sheffield, UK; Bateson
Centre, University of Sheffield, Sheffield, UK
kAreN leth NielseN • Statens Serum Institut, Copenhagen, Denmark; Department of
Clinical Microbiology, Rigshospitalet, Copenhagen, Denmark
toM oleseN • Philips BioCell A/S, Allerød, Denmark; BioSense Solutions ApS, Farum,
Denmark
toMAsz k. prAJsNAr • Krebs Institute, University of Sheffield, Sheffield, UK; Department
of Molecular Biology and Biotechnology, University of Sheffield, Sheffield, UK; Bateson
Centre, University of Sheffield, Sheffield, UK
stepheN A. reNshAw • Krebs Institute, University of Sheffield, Sheffield, UK; Bateson
Centre, University of Sheffield, Sheffield, UK; Department of Infection, Immunity and
Cardiovascular Disease, University of Sheffield, Sheffield, UK
lydiA robert • LJP, CNRS UMR 8237, UPMC, Sorbonne Universités, Paris, France;
Micalis Institute, INRA, AgroParisTech, Université Paris-Saclay, Jouy-en- Josas, France
erik spilluM • Philips BioCell A/S, Allerød, Denmark; BioSense Solutions ApS, Farum,
Denmark
stepheN c. tAylor • Research, National Infectious Service, Public Health England,
Salisbury, UK
stepheN r. thoMAs • Research, National Infectious Service, Public Health England,
Salisbury, UK
MArk A. toleMAN • Department of Infection and Immunity, Cardiff University,
Cardiff, UK
MArtiN VAlVik • Philips BioCell A/S, Allerød, Denmark
siMoN J. wAddell • Department of Global Health and Infection, Brighton and Sussex
Medical School, University of Sussex, Brighton, UK
leticiA MurAro wildNer • Universidade Federal de Santa Catarina, Florianópolis,
Santa Catarina, Brazil; Department of Global Health and Infection, Brighton and
Sussex Medical School, University of Sussex, Brighton, UK
AlexANder williAMs • Krebs Institute, University of Sheffield, Sheffield, UK;
Department of Molecular Biology and Biotechnology, University of Sheffield, Sheffield,
UK; Bateson Centre, University of Sheffield, Sheffield, UK
ANN williAMs • National Infectious Service, Public Health England, Salisbury,
Wiltshire, UK
hAN xAio • School of Medicine, University of St Andrews, St Andrews, UK
Contributors